Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $8.95 trillion, total revenue of $4.62 trillion and a weighted average PE ratio of 43.66.
Market Cap
8.95T
Revenue
4.62T
Profits
205.05B
PE Ratio
43.66
Profit Margin
4.44%
Dividend Yield
0.39%
1054 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 999.96B | -2.39% | 2,934,022 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 613.10B | -0.76% | 8,136,277 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 433.12B | -2.33% | 7,589,144 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 377.21B | 0.23% | 3,209,608 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 315.57B | -1.87% | 11,153,829 | 65.77B |
| 6 | NVS | Novartis AG | 291.64B | -1.59% | 1,666,435 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 239.46B | -6.88% | 16,313,047 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 212.25B | -0.05% | 1,588,947 | 46.34B |
| 9 | NVO | Novo Nordisk A/S | 205.77B | 0.02% | 11,857,166 | 50.57B |
| 10 | AMGN | Amgen Inc. | 204.48B | -1.63% | 3,443,059 | 37.22B |
| 11 | ABT | Abbott Laboratories | 185.36B | 1.34% | 7,409,618 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 162.83B | 0.72% | 7,523,915 | 29.74B |
| 13 | PFE | Pfizer Inc. | 142.66B | 0.08% | 41,776,180 | 63.32B |
| 14 | DHR | Danaher Corporation | 138.84B | 1.29% | 2,950,883 | 25.11B |
| 15 | CVS | CVS Health Corporation | 134.44B | 0.90% | 5,377,254 | 405.62B |
| 16 | BMY | Bristol-Myers Squibb Company | 133.74B | 0.24% | 32,970,932 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 132.62B | 6.25% | 3,502,070 | 11.03B |
| 18 | SYK | Stryker Corporation | 130.88B | 4.76% | 2,627,587 | 25.84B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 119.47B | -1.34% | 1,510,458 | 12.59B |
| 20 | MDT | Medtronic plc | 110.95B | 1.51% | 6,785,321 | 36.36B |
| 21 | GSK | GSK plc | 102.72B | -0.35% | 4,530,774 | 44.05B |
| 22 | SNY | Sanofi | 102.70B | -0.30% | 2,602,800 | 55.89B |
| 23 | MCK | McKesson Corporation | 96.84B | -3.39% | 1,466,702 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 88.03B | 1.00% | 1,176,745 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 83.01B | 1.84% | 1,140,046 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 75.81B | -0.44% | 842,732 | 15.53B |
| 27 | CI | The Cigna Group | 74.53B | 1.08% | 1,789,347 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 70.19B | 3.64% | 20,380,051 | 21.00B |
| 29 | COR | Cencora, Inc. | 60.00B | -0.95% | 1,602,953 | 328.68B |
| 30 | CAH | Cardinal Health, Inc. | 55.18B | 2.42% | 2,094,490 | 250.74B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 53.84B | -1.52% | 3,154,339 | 28.42B |
| 32 | MDLN | Medline Inc. | 53.16B | 3.03% | 5,246,556 | 29.14B |
| 33 | ARGX | argenx SE | 51.97B | -2.70% | 257,858 | 5.32B |
| 34 | EW | Edwards Lifesciences Corporation | 51.14B | 3.20% | 3,962,269 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 46.90B | 2.77% | 1,727,541 | 22.23B |
| 36 | HUM | Humana Inc. | 44.97B | 2.92% | 1,394,376 | 145.68B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 44.79B | 1.57% | 1,208,910 | 4.45B |
| 38 | HLN | Haleon plc | 42.85B | -0.71% | 13,100,336 | 14.80B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 40.16B | -1.57% | 6,208,662 | 17.32B |
| 40 | A | Agilent Technologies, Inc. | 39.48B | 1.03% | 1,795,432 | 7.23B |
| 41 | RVMD | Revolution Medicines, Inc. | 38.79B | -2.71% | 1,827,053 | - |
| 42 | NTRA | Natera, Inc. | 38.72B | 0.97% | 1,156,395 | 2.50B |
| 43 | IQV | IQVIA Holdings Inc. | 38.41B | -0.71% | 1,644,725 | 16.98B |
| 44 | WAT | Waters Corporation | 36.79B | -0.68% | 1,162,332 | 3.77B |
| 45 | ONC | BeOne Medicines AG | 34.88B | -0.71% | 359,521 | 5.74B |
| 46 | ALC | Alcon Inc. | 34.03B | 1.84% | 1,897,665 | 10.63B |
| 47 | VEEV | Veeva Systems Inc. | 33.50B | 1.21% | 2,608,933 | 3.32B |
| 48 | DXCM | DexCom, Inc. | 32.95B | 4.63% | 9,188,019 | 4.97B |
| 49 | RPRX | Royalty Pharma plc | 32.92B | -2.16% | 2,747,780 | 2.44B |
| 50 | ZTS | Zoetis Inc. | 32.32B | -0.25% | 5,060,767 | 9.53B |
| 51 | CNC | Centene Corporation | 31.50B | 2.48% | 6,865,824 | 180.30B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 31.50B | 2.51% | 4,368,985 | 21.27B |
| 53 | RMD | ResMed Inc. | 31.04B | 2.00% | 1,466,068 | 5.54B |
| 54 | ILMN | Illumina, Inc. | 29.92B | -3.38% | 2,612,023 | 4.49B |
| 55 | BIIB | Biogen Inc. | 29.82B | -0.56% | 940,994 | 10.03B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.48B | 7.21% | 3,400,185 | 4.80B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.95B | 2.03% | 216,287 | 4.13B |
| 58 | DGX | Quest Diagnostics Incorporated | 25.60B | -0.45% | 839,251 | 11.56B |
| 59 | PHG | Koninklijke Philips N.V. | 25.54B | -0.27% | 1,078,298 | 20.18B |
| 60 | LH | Labcorp Holdings Inc. | 24.87B | -0.58% | 726,945 | 14.35B |
| 61 | WST | West Pharmaceutical Services, Inc. | 24.49B | 2.05% | 643,102 | 3.33B |
| 62 | INCY | Incyte Corporation | 24.01B | -0.91% | 1,419,133 | 5.82B |
| 63 | ROIV | Roivant Sciences Ltd. | 23.97B | -1.74% | 5,986,826 | 8.26M |
| 64 | BNTX | BioNTech SE | 23.33B | 1.84% | 1,119,581 | 3.23B |
| 65 | STE | STERIS plc | 22.67B | 1.86% | 776,776 | 5.94B |
| 66 | MRNA | Moderna, Inc. | 22.01B | 0.58% | 5,176,713 | 2.23B |
| 67 | UTHR | United Therapeutics Corporation | 21.92B | -0.27% | 427,627 | 3.17B |
| 68 | INSM | Insmed Incorporated | 21.34B | -0.15% | 3,546,862 | 819.56M |
| 69 | GH | Guardant Health, Inc. | 21.31B | -1.95% | 2,016,393 | 1.18B |
| 70 | VTRS | Viatris Inc. | 20.53B | 0.40% | 8,797,332 | 14.56B |
| 71 | THC | Tenet Healthcare Corporation | 20.13B | -1.88% | 1,166,191 | 21.81B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.76B | 3.25% | 2,246,993 | 8.41B |
| 73 | GMAB | Genmab A/S | 17.44B | -0.66% | 1,739,500 | 3.90B |
| 74 | NBIX | Neurocrine Biosciences, Inc. | 16.90B | -0.34% | 1,515,977 | 3.37B |
| 75 | ASND | Ascendis Pharma A/S | 16.05B | -0.19% | 622,951 | 998.25M |
| 76 | MEDP | Medpace Holdings, Inc. | 16.00B | -0.66% | 249,534 | 2.78B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.80B | -0.51% | 1,493,478 | 4.60B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 15.63B | -0.16% | 1,366,942 | 579.96M |
| 79 | SOLV | Solventum Corporation | 15.25B | 3.08% | 1,285,094 | 8.26B |
| 80 | DVA | DaVita Inc. | 15.00B | -2.67% | 1,346,595 | 13.84B |
| 81 | BAX | Baxter International Inc. | 14.53B | 7.42% | 10,447,411 | 11.47B |
| 82 | COO | The Cooper Companies, Inc. | 14.48B | 2.64% | 2,810,067 | 4.23B |
| 83 | EXEL | Exelixis, Inc. | 13.84B | 3.83% | 4,270,137 | 2.38B |
| 84 | FMS | Fresenius Medical Care AG | 13.68B | -1.56% | 1,430,850 | 22.20B |
| 85 | SNN | Smith & Nephew plc | 13.52B | 1.87% | 1,692,243 | 6.30B |
| 86 | RVTY | Revvity, Inc. | 12.85B | 2.40% | 2,589,124 | 2.90B |
| 87 | ELAN | Elanco Animal Health Incorporated | 12.85B | -2.46% | 5,391,361 | 4.89B |
| 88 | PEN | Penumbra, Inc. | 12.72B | 0.57% | 328,453 | 1.50B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.67B | 1.26% | 4,524,998 | 14.37B |
| 90 | ALGN | Align Technology, Inc. | 12.38B | 2.21% | 998,781 | 4.14B |
| 91 | ICLR | ICON Public Limited Company | 12.22B | -3.15% | 1,212,123 | 8.29B |
| 92 | CORT | Corcept Therapeutics Incorporated | 12.19B | -1.48% | 1,688,568 | 830.81M |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.12B | 1.61% | 1,268,708 | 622.01M |
| 94 | PODD | Insulet Corporation | 11.75B | 2.63% | 1,408,006 | 2.90B |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.60B | -0.04% | 1,847,046 | 3.24B |
| 96 | TECH | Bio-Techne Corporation | 11.24B | 0.07% | 3,285,560 | 1.21B |
| 97 | EHC | Encompass Health Corporation | 11.16B | 1.26% | 1,136,459 | 6.07B |
| 98 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.14B | 3.14% | 463,917 | 1.28B |
| 99 | CRL | Charles River Laboratories International, Inc. | 11.12B | -0.71% | 608,143 | 4.03B |
| 100 | GMED | Globus Medical, Inc. | 11.06B | 3.39% | 914,158 | 3.10B |
| 101 | AXSM | Axsome Therapeutics, Inc. | 10.86B | -3.19% | 962,869 | 708.24M |
| 102 | ABVX | ABIVAX Société Anonyme | 10.64B | -0.11% | 941,540 | 5.67M |
| 103 | SMMT | Summit Therapeutics Inc. | 10.41B | 0.19% | 3,451,628 | - |
| 104 | CYTK | Cytokinetics, Incorporated | 10.38B | -0.88% | 2,239,504 | 105.82M |
| 105 | ENSG | The Ensign Group, Inc. | 10.24B | -0.52% | 314,680 | 5.49B |
| 106 | UHS | Universal Health Services, Inc. | 10.23B | 0.36% | 986,243 | 18.11B |
| 107 | RDY | Dr. Reddy's Laboratories Limited | 10.22B | 1.86% | 3,493,520 | 3.50B |
| 108 | MOH | Molina Healthcare, Inc. | 10.15B | -0.43% | 664,158 | 42.47B |
| 109 | GKOS | Glaukos Corporation | 10.07B | 2.49% | 1,108,936 | 612.84M |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.07B | 0.01% | 1,059,851 | - |
| 111 | HSIC | Henry Schein, Inc. | 9.85B | 0.89% | 1,899,695 | 13.38B |
| 112 | BRKR | Bruker Corporation | 9.79B | 2.34% | 2,440,238 | 3.46B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 9.76B | -0.33% | 1,367,693 | 1.51B |
| 114 | OSCR | Oscar Health, Inc. | 9.26B | -1.54% | 3,387,831 | 13.30B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.25B | -8.37% | 1,172,009 | 440.48M |
| 116 | AVTR | Avantor, Inc. | 9.25B | -0.80% | 9,035,596 | 6.56B |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 9.06B | 5.25% | 3,205,252 | 874.09M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 8.96B | 2.84% | 295,491 | 2.59B |
| 119 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | 0.29% | 1,744,760 | 42.16M |
| 120 | QGEN | Qiagen N.V. | 8.75B | 2.25% | 2,298,466 | 2.10B |
| 121 | HQY | HealthEquity, Inc. | 8.72B | 3.73% | 897,931 | 1.34B |
| 122 | ATR | AptarGroup, Inc. | 8.70B | 2.10% | 642,498 | 3.93B |
| 123 | PRAX | Praxis Precision Medicines, Inc. | 8.52B | -0.75% | 315,002 | 7.46M |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.51B | -3.19% | 451,166 | 74.06M |
| 125 | SYRE | Spyre Therapeutics, Inc. | 8.35B | -3.46% | 898,397 | - |
| 126 | ALKS | Alkermes plc | 8.31B | 1.10% | 1,835,762 | 1.67B |
| 127 | TEM | Tempus AI, Inc. | 8.31B | 4.97% | 5,543,552 | 1.43B |
| 128 | RGEN | Repligen Corporation | 8.30B | 4.29% | 1,010,518 | 785.10M |
| 129 | KYMR | Kymera Therapeutics, Inc. | 8.25B | -2.99% | 666,797 | 51.48M |
| 130 | IMVT | Immunovant, Inc. | 7.95B | -0.28% | 704,172 | - |
| 131 | PCVX | Vaxcyte, Inc. | 7.73B | -1.02% | 774,758 | - |
| 132 | IBRX | ImmunityBio, Inc. | 7.49B | -0.28% | 8,755,817 | 140.98M |
| 133 | LQDA | Liquidia Corporation | 7.46B | -0.31% | 1,101,291 | 288.07M |
| 134 | HIMS | Hims & Hers Health, Inc. | 7.13B | 10.98% | 14,795,997 | 2.37B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.04B | 3.56% | 964,316 | 217.17M |
| 136 | PACS | PACS Group, Inc. | 7.04B | -3.28% | 1,200,009 | 5.43B |
| 137 | CHE | Chemed Corporation | 7.04B | 1.56% | 190,207 | 2.60B |
| 138 | GRFS | Grifols, S.A. | 6.92B | -0.13% | 373,259 | 8.48B |
| 139 | COGT | Cogent Biosciences, Inc. | 6.64B | -0.18% | 1,405,975 | - |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.59B | 1.56% | 8,243,971 | 1.55B |
| 141 | TGTX | TG Therapeutics, Inc. | 6.54B | -11.26% | 6,421,976 | 799.54M |
| 142 | MIRM | Mirum Pharmaceuticals, Inc. | 6.38B | -1.28% | 500,280 | 569.61M |
| 143 | BLLN | BillionToOne, Inc. | 6.32B | -0.92% | 843,233 | 354.54M |
| 144 | TWST | Twist Bioscience Corporation | 6.29B | 10.39% | 2,937,493 | 431.80M |
| 145 | ERAS | Erasca, Inc. | 6.19B | -1.71% | 2,749,390 | - |
| 146 | TFX | Teleflex Incorporated | 6.18B | 2.19% | 1,009,652 | 2.13B |
| 147 | CGON | CG Oncology, Inc. | 6.10B | -2.87% | 625,946 | 5.07M |
| 148 | BLTE | Belite Bio, Inc | 6.09B | -2.41% | 191,495 | - |
| 149 | XENE | Xenon Pharmaceuticals Inc. | 6.02B | -0.65% | 540,699 | 7.50M |
| 150 | AMRX | Amneal Pharmaceuticals, Inc. | 6.01B | 2.89% | 2,487,790 | 3.12B |
| 151 | HNGE | Hinge Health, Inc. | 6.01B | 3.94% | 1,671,658 | 646.34M |
| 152 | BLCO | Bausch + Lomb Corporation | 5.99B | -0.83% | 429,057 | 5.32B |
| 153 | TXG | 10x Genomics, Inc. | 5.97B | -0.55% | 3,397,349 | 638.78M |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 5.80B | -0.84% | 841,858 | 1.34M |
| 155 | LGND | Ligand Pharmaceuticals Incorporated | 5.79B | 1.56% | 191,742 | 274.48M |
| 156 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.73B | -1.25% | 785,346 | 840.85M |
| 157 | ORKA | Oruka Therapeutics, Inc. | 5.72B | -1.78% | 807,266 | - |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.68B | 0.15% | 1,367,721 | 1.01B |
| 159 | STVN | Stevanato Group S.p.A. | 5.62B | 3.73% | 786,535 | 1.39B |
| 160 | DFTX | Definium Therapeutics, Inc. | 5.55B | -3.98% | 1,902,440 | - |
| 161 | SRRK | Scholar Rock Holding Corporation | 5.49B | -3.07% | 905,226 | - |
| 162 | MMED | MiniMed Group, Inc. | 5.36B | 5.82% | 921,665 | 3.10B |
| 163 | RDNT | RadNet, Inc. | 5.25B | 4.74% | 791,395 | 2.14B |
| 164 | SHC | Sotera Health Company | 5.13B | 0.73% | 1,727,276 | 1.19B |
| 165 | TVTX | Travere Therapeutics, Inc. | 5.11B | -1.63% | 1,906,548 | 536.20M |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.11B | 0.61% | 1,622,286 | 1.58B |
| 167 | CRSP | CRISPR Therapeutics AG | 4.88B | 3.29% | 1,401,801 | 13.39M |
| 168 | DYN | Dyne Therapeutics, Inc. | 4.71B | 0.24% | 2,130,328 | - |
| 169 | CAI | Caris Life Sciences, Inc. | 4.61B | 4.15% | 4,902,413 | 907.29M |
| 170 | INDV | Indivior Pharmaceuticals, Inc. | 4.56B | -6.60% | 6,683,682 | 1.33B |
| 171 | LIVN | LivaNova PLC | 4.53B | 2.89% | 660,618 | 1.43B |
| 172 | NVST | Envista Holdings Corporation | 4.45B | 0.22% | 3,015,547 | 2.81B |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 4.39B | -1.01% | 1,368,071 | 1.10B |
| 174 | WAY | Waystar Holding Corp. | 4.35B | 7.34% | 3,819,129 | 1.21B |
| 175 | PBLS | Parabilis Medicines, Inc. | 4.32B | -0.06% | 696,195 | - |
| 176 | ICUI | ICU Medical, Inc. | 4.32B | 2.63% | 579,119 | 2.16B |
| 177 | CELC | Celcuity Inc. | 4.28B | 1.55% | 557,329 | - |
| 178 | MANE | Veradermics, Incorporated | 4.26B | -2.96% | 2,765,540 | - |
| 179 | ITGR | Integer Holdings Corporation | 4.23B | 2.67% | 12,626,685 | 1.86B |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.13B | -0.13% | 770,688 | - |
| 181 | IRTC | iRhythm Holdings, Inc. | 4.10B | 6.39% | 704,840 | 787.85M |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.09B | -0.27% | 1,603,567 | 10.68M |
| 183 | LFST | LifeStance Health Group, Inc. | 4.09B | 0.57% | 3,422,858 | 1.49B |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 4.06B | 0.16% | 606,201 | 2.23B |
| 185 | ELVN | Enliven Therapeutics, Inc. | 4.05B | 5.89% | 2,828,490 | - |
| 186 | HAE | Haemonetics Corporation | 3.94B | 1.46% | 1,058,090 | 1.33B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.94B | 0.11% | 1,981,277 | 56.99M |
| 188 | DOCS | Doximity, Inc. | 3.89B | 3.59% | 2,947,939 | 644.86M |
| 189 | VKTX | Viking Therapeutics, Inc. | 3.80B | 2.74% | 1,598,815 | - |
| 190 | LEGN | Legend Biotech Corporation | 3.68B | 2.48% | 2,045,216 | 1.14B |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 3.68B | 2.39% | 2,591,235 | 308.08M |
| 192 | DNLI | Denali Therapeutics Inc. | 3.67B | 0.56% | 1,476,104 | - |
| 193 | VCYT | Veracyte, Inc. | 3.61B | -3.17% | 2,010,947 | 561.90M |
| 194 | OGN | Organon & Co. | 3.56B | 0.07% | 1,908,393 | 6.13B |
| 195 | OPCH | Option Care Health, Inc. | 3.55B | 2.91% | 2,704,738 | 5.69B |
| 196 | NHC | National HealthCare Corporation | 3.48B | -1.45% | 106,063 | 1.53B |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.47B | -2.02% | 855,938 | 236.00M |
| 198 | WRBY | Warby Parker Inc. | 3.47B | 5.96% | 2,889,091 | 890.57M |
| 199 | GPCR | Structure Therapeutics Inc. | 3.44B | 0.67% | 326,381 | - |
| 200 | BKD | Brookdale Senior Living Inc. | 3.43B | -1.58% | 5,551,517 | 3.00B |
| 201 | TLX | Telix Pharmaceuticals Limited | 3.40B | 1.31% | 121,755 | 803.79M |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.37B | -0.28% | 395,796 | 225.27M |
| 203 | ALMS | Alumis Inc. | 3.33B | -7.54% | 1,387,984 | 8.40M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.24B | -3.43% | 1,570,531 | 415.62M |
| 205 | NAMS | NewAmsterdam Pharma Company N.V. | 3.21B | -1.08% | 1,012,543 | 22.57M |
| 206 | MBX | MBX Biosciences, Inc. | 3.07B | -2.31% | 390,732 | - |
| 207 | QURE | uniQure N.V. | 3.06B | 0.99% | 1,056,048 | 18.67M |
| 208 | RGC | Regencell Bioscience Holdings Limited | 3.04B | -0.81% | 293,362 | - |
| 209 | ALHC | Alignment Healthcare, Inc. | 3.02B | -1.95% | 11,076,699 | 4.58B |
| 210 | GRAL | GRAIL, Inc. | 3.02B | 2.49% | 366,293 | 156.12M |
| 211 | PRVA | Privia Health Group, Inc. | 3.00B | 0.51% | 642,941 | 2.25B |
| 212 | CLDX | Celldex Therapeutics, Inc. | 2.96B | -0.97% | 1,635,238 | 865.00K |
| 213 | IRON | Disc Medicine, Inc. | 2.93B | -0.90% | 293,907 | - |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 2.85B | 3.27% | 3,425,194 | 3.37B |
| 215 | XRAY | DENTSPLY SIRONA Inc. | 2.83B | 5.68% | 7,152,807 | 3.68B |
| 216 | TMDX | TransMedics Group, Inc. | 2.82B | 6.59% | 1,517,956 | 635.89M |
| 217 | ESTA | Establishment Labs Holdings Inc. | 2.73B | 0.28% | 850,205 | 229.58M |
| 218 | SUPN | Supernus Pharmaceuticals, Inc. | 2.68B | 3.07% | 4,518,516 | 830.44M |
| 219 | ATAI | AtaiBeckley Inc. | 2.66B | - | 14,782,849 | 3.49M |
| 220 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | 3.86% | 831,325 | 535.08M |
| 221 | BHC | Bausch Health Companies Inc. | 2.62B | 1.60% | 9,458,764 | 10.85B |
| 222 | PLSE | Pulse Biosciences, Inc. | 2.61B | 7.40% | 352,342 | 751.00K |
| 223 | IMNM | Immunome, Inc. | 2.61B | 1.10% | 1,771,166 | 4.02M |
| 224 | NEOG | Neogen Corporation | 2.59B | -1.16% | 5,097,502 | 870.40M |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | 3.24% | 246,981 | 1.46B |
| 226 | BEAM | Beam Therapeutics Inc. | 2.58B | 1.53% | 1,295,033 | 164.01M |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.54B | -1.92% | 1,255,644 | - |
| 228 | KOD | Kodiak Sciences Inc. | 2.49B | -4.21% | 578,665 | - |
| 229 | CDNA | CareDx, Inc. | 2.48B | 9.47% | 2,927,216 | 458.09M |
| 230 | PGNY | Progyny, Inc. | 2.47B | 1.28% | 901,390 | 1.29B |
| 231 | PBH | Prestige Consumer Healthcare Inc. | 2.46B | 3.39% | 832,274 | 1.09B |
| 232 | AXGN | Axogen, Inc. | 2.46B | 8.34% | 1,402,096 | 251.17M |
| 233 | RARE | Ultragenyx Pharmaceutical Inc. | 2.46B | 0.44% | 2,085,743 | 670.00M |
| 234 | NRIX | Nurix Therapeutics, Inc. | 2.41B | 0.04% | 1,351,763 | 36.77M |
| 235 | NKTR | Nektar Therapeutics | 2.38B | -0.11% | 611,869 | 55.63M |
| 236 | LMAT | LeMaitre Vascular, Inc. | 2.37B | 2.26% | 321,109 | 256.28M |
| 237 | VCEL | Vericel Corporation | 2.36B | 0.20% | 497,961 | 306.30M |
| 238 | PGEN | Precigen, Inc. | 2.36B | 5.42% | 7,441,191 | 31.60M |
| 239 | VERA | Vera Therapeutics, Inc. | 2.31B | 0.40% | 1,511,399 | - |
| 240 | HTFL | HeartFlow, Inc. | 2.31B | 6.06% | 881,477 | 191.42M |
| 241 | CLOV | Clover Health Investments, Corp. | 2.28B | 3.84% | 3,926,900 | 2.21B |
| 242 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | 1.02% | 1,031,859 | - |
| 243 | PHVS | Pharvaris N.V. | 2.25B | -1.13% | 254,479 | - |
| 244 | KLRA | Kailera Therapeutics, Inc. | 2.24B | 2.24% | 357,530 | - |
| 245 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.24B | -0.69% | 1,685,578 | -665.00K |
| 246 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.24B | -1.89% | 3,190,273 | 885.72M |
| 247 | SION | Sionna Therapeutics, Inc. | 2.22B | 4.52% | 509,032 | - |
| 248 | SLS | SELLAS Life Sciences Group, Inc. | 2.21B | 12.09% | 6,968,613 | - |
| 249 | BFLY | Butterfly Network, Inc. | 2.19B | 15.61% | 12,877,153 | 112.14M |
| 250 | NUVB | Nuvation Bio Inc. | 2.14B | -2.69% | 5,569,348 | 143.05M |
| 251 | ADUS | Addus HomeCare Corporation | 2.14B | 1.13% | 250,077 | 1.48B |
| 252 | VRDN | Viridian Therapeutics, Inc. | 2.13B | 2.06% | 1,833,926 | 70.92M |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.10B | -0.98% | 720,678 | 1.93B |
| 254 | COAG | Hemab Therapeutics Holdings, Inc. | 2.10B | -5.36% | 699,550 | - |
| 255 | AVAH | Aveanna Healthcare Holdings Inc. | 2.09B | 2.34% | 1,806,572 | 2.52B |
| 256 | SGRY | Surgery Partners, Inc. | 2.08B | 4.29% | 1,257,191 | 3.34B |
| 257 | UFPT | UFP Technologies, Inc. | 2.07B | 5.00% | 189,746 | 631.64M |
| 258 | HRMY | Harmony Biosciences Holdings, Inc. | 2.06B | 1.02% | 882,818 | 899.11M |
| 259 | ZLAB | Zai Lab Limited | 2.04B | -0.49% | 324,306 | 453.28M |
| 260 | HCM | HUTCHMED (China) Limited | 2.04B | 3.77% | 82,100 | 549.12M |
| 261 | NEO | NeoGenomics, Inc. | 2.04B | 3.60% | 2,974,027 | 766.30M |
| 262 | ADMA | ADMA Biologics, Inc. | 2.03B | 3.31% | 2,572,850 | 509.86M |
| 263 | PVLA | Palvella Therapeutics, Inc. | 2.02B | 1.25% | 145,921 | - |
| 264 | WGS | GeneDx Holdings Corp. | 2.01B | 4.22% | 1,738,968 | 454.43M |
| 265 | BHVN | Biohaven Ltd. | 2.01B | -0.96% | 1,590,030 | - |
| 266 | NBTX | Nanobiotix S.A. | 1.97B | 1.30% | 152,044 | 38.27M |
| 267 | ATRC | AtriCure, Inc. | 1.97B | 2.54% | 1,129,443 | 569.62M |
| 268 | ZBIO | Zenas BioPharma, Inc. | 1.97B | -0.99% | 429,284 | 10.00M |
| 269 | RAPP | Rapport Therapeutics, Inc. | 1.95B | -0.46% | 315,229 | 20.00M |
| 270 | GHRS | GH Research PLC | 1.93B | 0.43% | 241,300 | - |
| 271 | IOVA | Iovance Biotherapeutics, Inc. | 1.93B | 6.02% | 13,022,195 | 285.61M |
| 272 | TYRA | Tyra Biosciences, Inc. | 1.91B | 0.50% | 507,316 | - |
| 273 | URGN | UroGen Pharma Ltd. | 1.88B | 0.92% | 964,790 | 140.49M |
| 274 | SNDA | Sonida Senior Living, Inc. | 1.88B | -0.35% | 354,367 | 367.34M |
| 275 | ALMR | Alamar Biosciences, Inc. | 1.88B | 6.74% | 183,693 | 87.16M |
| 276 | AUPH | Aurinia Pharmaceuticals Inc. | 1.87B | -2.08% | 1,404,085 | 298.30M |
| 277 | FBRX | Forte Biosciences, Inc. | 1.87B | 0.01% | 649,705 | - |
| 278 | TSHA | Taysha Gene Therapies, Inc. | 1.85B | -1.37% | 1,963,182 | 7.47M |
| 279 | MESO | Mesoblast Limited | 1.85B | 2.12% | 228,637 | 65.38M |
| 280 | OCUL | Ocular Therapeutix, Inc. | 1.84B | 2.82% | 3,327,378 | 52.06M |
| 281 | STOK | Stoke Therapeutics, Inc. | 1.84B | 2.43% | 3,152,000 | 27.59M |
| 282 | GENB | Generate Biomedicines, Inc. | 1.84B | 2.43% | 275,564 | 30.30M |
| 283 | AGIO | Agios Pharmaceuticals, Inc. | 1.82B | 1.73% | 1,189,503 | 98.34M |
| 284 | ENOV | Enovis Corporation | 1.81B | 7.79% | 1,590,536 | 2.28B |
| 285 | FTRE | Fortrea Holdings Inc. | 1.80B | -1.20% | 3,140,288 | 2.68B |
| 286 | KARD | Kardigan, Inc. | 1.78B | -4.08% | 224,811 | - |
| 287 | NVCR | NovoCure Limited | 1.78B | 3.23% | 1,642,986 | 699.19M |
| 288 | ABCL | AbCellera Biologics Inc. | 1.78B | 2.10% | 3,405,576 | 79.21M |
| 289 | LKFT | Lakefront Biotherapeutics NV | 1.78B | -1.73% | 200,171 | 1.20B |
| 290 | DMRA | Damora Therapeutics, Inc. | 1.76B | -1.48% | 227,770 | - |
| 291 | OMCL | Omnicell, Inc. | 1.71B | 6.45% | 1,112,296 | 1.25B |
| 292 | SNDX | Syndax Pharmaceuticals, Inc. | 1.70B | 1.00% | 1,611,110 | 217.17M |
| 293 | ANIP | ANI Pharmaceuticals, Inc. | 1.70B | 1.03% | 432,418 | 923.71M |
| 294 | BCAX | Bicara Therapeutics Inc. | 1.69B | -5.02% | 398,978 | - |
| 295 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | 6.00% | 14,721,700 | 66.41M |
| 296 | SRPT | Sarepta Therapeutics, Inc. | 1.68B | 6.86% | 3,799,659 | 2.18B |
| 297 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.66B | -2.28% | 2,047,048 | 204.73M |
| 298 | TRLV | Trulieve Cannabis Corp. | 1.65B | -0.58% | 584,024 | 1.17B |
| 299 | IMCR | Immunocore Holdings plc | 1.65B | -4.08% | 645,651 | 412.81M |
| 300 | ASTH | Astrana Health, Inc. | 1.62B | 0.98% | 526,898 | 3.53B |
| 301 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | 4.81% | 259,650 | - |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.61B | 0.47% | 519,196 | 1.86B |
| 303 | ANAB | AnaptysBio, Inc. | 1.59B | 0.56% | 433,731 | 232.39M |
| 304 | SEPN | Septerna, Inc. | 1.58B | 1.54% | 201,795 | 72.26M |
| 305 | BLFS | BioLife Solutions, Inc. | 1.57B | 2.78% | 575,980 | 101.66M |
| 306 | AGL | agilon health, inc. | 1.57B | 2.73% | 425,953 | 5.82B |
| 307 | ZYME | Zymeworks Inc. | 1.56B | -0.59% | 398,336 | 81.26M |
| 308 | ATEC | Alphatec Holdings, Inc. | 1.56B | 6.62% | 4,589,416 | 787.08M |
| 309 | CNMD | CONMED Corporation | 1.55B | 12.01% | 1,197,192 | 1.37B |
| 310 | ARDT | Ardent Health, Inc. | 1.54B | 0.75% | 412,590 | 6.43B |
| 311 | INVA | Innoviva, Inc. | 1.53B | -0.95% | 799,108 | 420.69M |
| 312 | AAPG | Ascentage Pharma Group International | 1.53B | -3.59% | 14,157 | 82.08M |
| 313 | INNV | InnovAge Holding Corp. | 1.52B | -1.14% | 346,965 | 949.17M |
| 314 | CMPS | COMPASS Pathways plc | 1.52B | -0.88% | 2,774,451 | - |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.51B | 1.52% | 313,332 | 20.00M |
| 316 | PAHC | Phibro Animal Health Corporation | 1.51B | 2.26% | 297,908 | 1.50B |
| 317 | NTLA | Intellia Therapeutics, Inc. | 1.50B | 0.84% | 3,319,884 | 66.09M |
| 318 | INSP | Inspire Medical Systems, Inc. | 1.50B | 4.00% | 992,132 | 915.25M |
| 319 | VIR | Vir Biotechnology, Inc. | 1.50B | 2.77% | 1,241,593 | 65.50M |
| 320 | PRGO | Perrigo Company plc | 1.48B | 5.64% | 3,289,224 | 4.18B |
| 321 | XERS | Xeris Biopharma Holdings, Inc. | 1.47B | 0.62% | 1,947,113 | 314.85M |
| 322 | HROW | Harrow, Inc. | 1.46B | 0.83% | 400,524 | 268.68M |
| 323 | AHCO | AdaptHealth Corp. | 1.44B | 0.28% | 1,793,485 | 3.29B |
| 324 | XNCR | Xencor, Inc. | 1.44B | -4.01% | 714,423 | 97.36M |
| 325 | MLTX | MoonLake Immunotherapeutics | 1.44B | -5.64% | 1,272,982 | - |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.41B | 5.08% | 373,728 | 95.13M |
| 327 | PNTG | The Pennant Group, Inc. | 1.40B | -0.35% | 255,503 | 1.02B |
| 328 | IART | Integra LifeSciences Holdings Corporation | 1.39B | 7.39% | 1,278,776 | 1.65B |
| 329 | PSNL | Personalis, Inc. | 1.38B | 4.27% | 4,849,409 | 64.52M |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.38B | -0.60% | 278,249 | - |
| 331 | TNDM | Tandem Diabetes Care, Inc. | 1.38B | 3.13% | 3,327,932 | 1.03B |
| 332 | AZTA | Azenta, Inc. | 1.38B | 6.22% | 1,111,271 | 596.48M |
| 333 | ALVO | Alvotech | 1.35B | -8.01% | 1,026,989 | 562.04M |
| 334 | SVRA | Savara Inc. | 1.35B | -2.38% | 1,639,560 | - |
| 335 | ABSI | Absci Corporation | 1.34B | 1.93% | 2,220,300 | 1.84M |
| 336 | AORT | Artivion, Inc. | 1.33B | 2.39% | 831,416 | 458.69M |
| 337 | GLUE | Monte Rosa Therapeutics, Inc. | 1.30B | -6.90% | 2,317,064 | 42.95M |
| 338 | AMN | AMN Healthcare Services, Inc. | 1.28B | -1.87% | 975,340 | 3.42B |
| 339 | CERT | Certara, Inc. | 1.27B | 0.99% | 3,668,401 | 419.75M |
| 340 | AVLN | Avalyn Pharma Inc. | 1.26B | -1.01% | 110,853 | - |
| 341 | FRNM | Freenome, Inc. | 1.24B | -1.26% | 755,295 | 34.24M |
| 342 | ETON | Eton Pharmaceuticals, Inc. | 1.24B | -2.76% | 470,559 | 86.93M |
| 343 | IMTX | Immatics N.V. | 1.23B | 4.16% | 257,479 | 43.00M |
| 344 | ARDX | Ardelyx, Inc. | 1.23B | 0.61% | 2,919,404 | 427.68M |
| 345 | AKTS | Aktis Oncology, Inc. | 1.23B | 0.72% | 314,679 | 8.28M |
| 346 | LBRX | LB Pharmaceuticals Inc | 1.23B | 6.89% | 871,789 | - |
| 347 | OMDA | Omada Health, Inc. | 1.22B | 3.38% | 861,357 | 283.30M |
| 348 | NVAX | Novavax, Inc. | 1.22B | 1.23% | 2,580,452 | 596.34M |
| 349 | MNKD | MannKind Corporation | 1.21B | -2.81% | 5,276,520 | 360.78M |
| 350 | TDOC | Teladoc Health, Inc. | 1.21B | -0.45% | 7,278,525 | 2.49B |
| 351 | INBX | Inhibrx Biosciences, Inc. | 1.21B | 0.82% | 134,530 | 1.30M |
| 352 | STAA | STAAR Surgical Company | 1.21B | -0.08% | 1,061,224 | 290.38M |
| 353 | QDEL | QuidelOrtho Corporation | 1.21B | 5.61% | 1,381,948 | 2.66B |
| 354 | USPH | U.S. Physical Therapy, Inc. | 1.18B | -1.58% | 262,452 | 787.69M |
| 355 | IRMD | IRADIMED CORPORATION | 1.17B | 0.77% | 214,735 | 86.34M |
| 356 | VOR | Vor Biopharma Inc. | 1.16B | 1.23% | 851,888 | - |
| 357 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | 0.54% | 374,253 | 796.33M |
| 358 | SDGR | Schrödinger, Inc. | 1.14B | 0.92% | 982,203 | 254.91M |
| 359 | AHG | Akso Health Group | 1.14B | -15.29% | 13,617 | 13.83M |
| 360 | JBIO | Jade Biosciences, Inc. | 1.14B | -3.04% | 651,162 | - |
| 361 | WVE | Wave Life Sciences Ltd. | 1.13B | 4.17% | 3,417,765 | 65.37M |
| 362 | BVS | Bioventus Inc. | 1.13B | 2.28% | 1,133,975 | 576.30M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 1.12B | 0.83% | 580,665 | - |
| 364 | SPTX | Seaport Therapeutics, Inc. | 1.11B | 0.93% | 139,527 | - |
| 365 | MGTX | MeiraGTx Holdings plc | 1.10B | 0.76% | 489,490 | 79.76M |
| 366 | ORIC | ORIC Pharmaceuticals, Inc. | 1.10B | -4.25% | 2,460,217 | - |
| 367 | LMRI | Lumexa Imaging Holdings, Inc. | 1.08B | 8.17% | 424,361 | 1.03B |
| 368 | DRTS | Alpha Tau Medical Ltd. | 1.08B | 1.10% | 330,489 | - |
| 369 | GDRX | GoodRx Holdings, Inc. | 1.07B | 2.93% | 769,892 | 787.89M |
| 370 | ANRO | Alto Neuroscience, Inc. | 1.06B | 0.74% | 409,065 | - |
| 371 | PCRX | Pacira BioSciences, Inc. | 1.06B | 1.93% | 1,166,570 | 734.86M |
| 372 | NUTX | Nutex Health Inc. | 1.05B | 3.73% | 117,160 | 879.95M |
| 373 | CRON | Cronos Group Inc. | 1.05B | - | 901,675 | 159.54M |
| 374 | PRCT | PROCEPT BioRobotics Corporation | 1.05B | -1.29% | 2,900,489 | 322.02M |
| 375 | EYPT | EyePoint, Inc. | 1.04B | 1.39% | 1,479,362 | 7.61M |
| 376 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 0.87% | 2,053,054 | 69.64M |
| 377 | IVA | Inventiva S.A. | 1.03B | -5.13% | 1,005,451 | 7.94M |
| 378 | GMRS | GMR Solutions Inc. | 1.01B | 0.93% | 381,231 | 5.83B |
| 379 | REPL | Replimune Group, Inc. | 1.00B | 6.34% | 11,770,444 | - |
| 380 | CGEM | Cullinan Therapeutics, Inc. | 998.69M | -1.52% | 386,608 | - |
| 381 | APMD | Apnimed, Inc. | 995.58M | - | 700,678 | 120.15M |
| 382 | OLMA | Olema Pharmaceuticals, Inc. | 985.28M | -1.48% | 763,685 | - |
| 383 | OPK | OPKO Health, Inc. | 977.69M | -0.76% | 4,621,719 | 587.90M |
| 384 | AVTX | Avalo Therapeutics, Inc. | 954.90M | -1.10% | 572,281 | 59.00K |
| 385 | SANA | Sana Biotechnology, Inc. | 953.68M | 1.60% | 2,490,024 | - |
| 386 | JANX | Janux Therapeutics, Inc. | 934.28M | 0.99% | 558,943 | 13.73M |
| 387 | CSTL | Castle Biosciences, Inc. | 928.40M | 8.54% | 777,610 | 357.28M |
| 388 | OMER | Omeros Corporation | 909.03M | 6.08% | 1,446,064 | 9.89M |
| 389 | AMPH | Amphastar Pharmaceuticals, Inc. | 891.56M | 1.40% | 413,179 | 720.53M |
| 390 | INMD | InMode Ltd. | 882.33M | 1.39% | 394,623 | 374.64M |
| 391 | TBPH | Theravance Biopharma, Inc. | 874.34M | 0.06% | 437,742 | 109.78M |
| 392 | TALK | Talkspace, Inc. | 872.74M | -0.19% | 1,428,392 | 238.37M |
| 393 | ODTX | Odyssey Therapeutics, Inc. | 868.03M | -4.23% | 141,344 | 1.06M |
| 394 | GLAS | Glass House Brands Inc. | 861.48M | 5.56% | 517,951 | 177.68M |
| 395 | ABUS | Arbutus Biopharma Corporation | 861.26M | 0.46% | 1,421,329 | 191.45M |
| 396 | ANNX | Annexon, Inc. | 860.17M | 2.94% | 2,691,799 | - |
| 397 | HSTM | HealthStream, Inc. | 827.67M | 1.03% | 150,759 | 321.12M |
| 398 | GERN | Geron Corporation | 821.15M | -0.78% | 19,560,706 | 196.12M |
| 399 | TENX | Tenax Therapeutics, Inc. | 820.85M | 4.60% | 2,000,706 | - |
| 400 | SIBN | SI-BONE, Inc. | 818.24M | 3.89% | 813,895 | 213.60M |
| 401 | KURA | Kura Oncology, Inc. | 815.84M | 2.00% | 1,154,634 | 71.64M |
| 402 | AVR | Anteris Technologies Global Corp. | 806.93M | 5.61% | 1,433,126 | 1.85M |
| 403 | DSGN | Design Therapeutics, Inc. | 798.54M | 4.76% | 477,912 | - |
| 404 | SSII | SS Innovations International, Inc. | 790.52M | -0.75% | 17,470 | 48.47M |
| 405 | DBVT | DBV Technologies S.A. | 789.92M | 0.59% | 304,565 | 5.04M |
| 406 | SLDB | Solid Biosciences Inc. | 789.57M | -0.50% | 905,525 | - |
| 407 | AURA | Aura Biosciences, Inc. | 776.51M | 0.43% | 422,232 | - |
| 408 | ACRS | Aclaris Therapeutics, Inc. | 772.34M | 6.35% | 1,952,022 | 8.37M |
| 409 | SGP | SpyGlass Pharma, Inc. | 758.27M | 0.67% | 103,535 | - |
| 410 | MNPR | Monopar Therapeutics Inc. | 747.85M | 3.04% | 489,203 | - |
| 411 | CADL | Candel Therapeutics, Inc. | 737.83M | 0.60% | 879,391 | - |
| 412 | IRWD | Ironwood Pharmaceuticals, Inc. | 727.59M | 4.49% | 3,818,187 | 361.51M |
| 413 | DRUG | Bright Minds Biosciences Inc. | 721.25M | 0.71% | 275,403 | - |
| 414 | PHAR | Pharming Group N.V. | 718.94M | -2.58% | 33,876 | 366.48M |
| 415 | OCS | Oculis Holding AG | 718.01M | 5.13% | 295,727 | 1.40M |
| 416 | EVO | Evotec SE | 713.37M | 1.57% | 79,031 | 859.03M |
| 417 | PHAT | Phathom Pharmaceuticals, Inc. | 713.28M | 2.63% | 1,534,000 | 239.66M |
| 418 | FTH | Faeth Therapeutics, Inc. | 704.79M | 0.37% | 287,950 | - |
| 419 | PHR | Phreesia, Inc. | 698.47M | 5.31% | 1,035,422 | 495.59M |
| 420 | CBLL | CeriBell, Inc. | 694.73M | 3.50% | 536,728 | 95.07M |
| 421 | RIGL | Rigel Pharmaceuticals, Inc. | 692.53M | 1.68% | 187,277 | 299.77M |
| 422 | CTMX | CytomX Therapeutics, Inc. | 690.12M | 2.26% | 3,796,119 | 35.54M |
| 423 | GYRE | Gyre Therapeutics, Inc. | 681.20M | 6.26% | 53,656 | 117.05M |
| 424 | NVCT | Nuvectis Pharma, Inc. | 680.95M | 0.37% | 204,620 | - |
| 425 | CLYM | Climb Bio, Inc. | 676.25M | -0.76% | 847,528 | - |
| 426 | TCMD | Tactile Systems Technology, Inc. | 671.73M | 5.72% | 152,914 | 343.52M |
| 427 | AGMB | AgomAb Therapeutics NV | 665.83M | 5.05% | 126,059 | - |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 660.88M | 1.98% | 210,117 | - |
| 429 | NGNE | Neurogene Inc. | 655.00M | -0.06% | 155,549 | 925.00K |
| 430 | ACHV | Achieve Life Sciences, Inc. | 648.81M | -1.56% | 914,034 | - |
| 431 | CBIO | Crescent Biopharma, Inc. | 636.45M | 2.76% | 236,363 | 11.88M |
| 432 | ALLO | Allogene Therapeutics, Inc. | 635.08M | -2.13% | 7,039,923 | 22.00K |
| 433 | TLRY | Tilray Brands, Inc. | 629.25M | 2.20% | 5,998,174 | 915.45M |
| 434 | BWAY | BrainsWay Ltd. | 628.36M | 3.81% | 86,590 | 56.22M |
| 435 | ANGO | AngioDynamics, Inc. | 627.01M | 2.57% | 774,017 | 320.17M |
| 436 | MDXG | MiMedx Group, Inc. | 622.40M | 3.39% | 1,869,229 | 355.17M |
| 437 | RGNX | REGENXBIO Inc. | 614.56M | 2.79% | 812,898 | 87.82M |
| 438 | BBNX | Beta Bionics, Inc. | 600.61M | 4.05% | 2,820,102 | 119.01M |
| 439 | IMMX | Immix Biopharma, Inc. | 599.42M | 1.20% | 1,618,167 | - |
| 440 | CTNM | Contineum Therapeutics, Inc. | 599.30M | 2.84% | 315,034 | - |
| 441 | ZVRA | Zevra Therapeutics, Inc. | 594.40M | 5.73% | 1,753,740 | 122.29M |
| 442 | CRMD | CorMedix Inc. | 592.31M | 0.27% | 856,103 | 400.05M |
| 443 | DNA | Ginkgo Bioworks Holdings, Inc. | 584.00M | 10.51% | 1,421,386 | 151.40M |
| 444 | ALT | Altimmune, Inc. | 583.42M | 5.63% | 4,647,347 | 36.00K |
| 445 | MPLT | MapLight Therapeutics, Inc. | 569.09M | -3.61% | 999,857 | - |
| 446 | STTK | Shattuck Labs, Inc. | 559.00M | 3.11% | 989,705 | 1.00M |
| 447 | CTKB | Cytek Biosciences, Inc. | 556.60M | 2.13% | 889,840 | 204.17M |
| 448 | RLMD | Relmada Therapeutics, Inc. | 555.92M | -0.19% | 1,073,352 | - |
| 449 | SPRY | ARS Pharmaceuticals, Inc. | 542.20M | 6.43% | 2,143,695 | 98.99M |
| 450 | WEAV | Weave Communications, Inc. | 537.07M | 3.21% | 754,797 | 248.72M |
| 451 | KIDS | OrthoPediatrics Corp. | 536.05M | 3.37% | 359,242 | 243.30M |
| 452 | SLBT | SL Science Holding Limited | 531.75M | 24.39% | 198,630 | 3.27M |
| 453 | FDMT | 4D Molecular Therapeutics, Inc. | 527.47M | -0.88% | 463,651 | 88.24M |
| 454 | TECX | Tectonic Therapeutic, Inc. | 526.83M | -0.39% | 106,037 | - |
| 455 | ZURA | Zura Bio Limited | 524.39M | 1.66% | 435,191 | - |
| 456 | ARTV | Artiva Biotherapeutics, Inc. | 522.81M | 6.53% | 572,393 | 251.00K |
| 457 | ARVN | Arvinas, Inc. | 520.04M | 0.37% | 716,843 | 89.40M |
| 458 | ANL | Adlai Nortye Ltd. | 519.60M | -0.08% | 216,584 | 5.00M |
| 459 | RZLT | Rezolute, Inc. | 512.93M | 4.03% | 1,428,173 | - |
| 460 | TOI | The Oncology Institute, Inc. | 512.91M | 5.56% | 1,265,539 | 545.76M |
| 461 | PRME | Prime Medicine, Inc. | 507.54M | -3.77% | 3,953,390 | 4.03M |
| 462 | SLN | Silence Therapeutics plc | 504.46M | 1.81% | 536,745 | 839.00K |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 464 | VREX | Varex Imaging Corporation | 502.39M | 6.52% | 464,941 | 857.50M |
| 465 | VSTM | Verastem, Inc. | 500.00M | -1.90% | 1,288,075 | 49.59M |
| 466 | HELP | Cybin Inc. | 499.59M | 3.07% | 1,199,700 | - |
| 467 | OFIX | Orthofix Medical Inc. | 495.57M | 3.90% | 418,121 | 825.37M |
| 468 | EIKN | Eikon Therapeutics, Inc. | 495.37M | -0.65% | 256,654 | - |
| 469 | ASMB | Assembly Biosciences, Inc. | 488.20M | 1.00% | 193,303 | 71.10M |
| 470 | FLGT | Fulgent Genetics, Inc. | 484.54M | 6.40% | 504,817 | 323.93M |
| 471 | AUTL | Autolus Therapeutics plc | 484.38M | 22.15% | 13,440,416 | 92.62M |
| 472 | SRTA | Strata Critical Medical, Inc. | 480.22M | 10.56% | 1,506,495 | 228.58M |
| 473 | BIOA | BioAge Labs, Inc. | 479.20M | 19.25% | 3,533,722 | 10.32M |
| 474 | SOPH | SOPHiA GENETICS SA | 477.36M | 0.35% | 366,533 | 81.18M |
| 475 | VALN | Valneva SE | 476.79M | 2.01% | 7,569 | 180.25M |
| 476 | AQST | Aquestive Therapeutics, Inc. | 475.52M | 2.57% | 2,381,422 | 50.27M |
| 477 | PROK | ProKidney Corp. | 471.21M | 1.30% | 591,744 | 889.00K |
| 478 | NNNN | Anbio Biotechnology | 467.44M | 7.58% | 121,428 | 8.65M |
| 479 | SI | Shoulder Innovations, Inc. | 464.12M | -1.58% | 65,638 | 53.89M |
| 480 | CLPT | ClearPoint Neuro, Inc. | 461.24M | 2.95% | 747,003 | 42.28M |
| 481 | NPCE | NeuroPace, Inc. | 460.27M | 4.73% | 593,788 | 99.53M |
| 482 | KYTX | Kyverna Therapeutics, Inc. | 456.57M | 2.88% | 822,340 | - |
| 483 | QTTB | Q32 Bio Inc. | 451.37M | -3.28% | 328,944 | 53.74M |
| 484 | DCTH | Delcath Systems, Inc. | 450.16M | 6.71% | 579,882 | 90.44M |
| 485 | VMD | Viemed Healthcare, Inc. | 448.16M | 0.17% | 400,990 | 301.61M |
| 486 | SGMT | Sagimet Biosciences Inc. | 441.53M | 0.56% | 2,991,035 | - |
| 487 | PACB | Pacific Biosciences of California, Inc. | 441.05M | 1.43% | 3,553,631 | 160.03M |
| 488 | CABA | Cabaletta Bio, Inc. | 438.62M | 0.37% | 1,873,050 | - |
| 489 | PRTA | Prothena Corporation plc | 436.10M | 2.59% | 566,001 | 57.94M |
| 490 | PRLD | Prelude Therapeutics Incorporated | 435.39M | -4.57% | 288,744 | 16.72M |
| 491 | OVID | Ovid Therapeutics Inc. | 434.87M | 4.95% | 1,677,482 | 7.12M |
| 492 | CERS | Cerus Corporation | 433.28M | - | 4,577,302 | 221.55M |
| 493 | IKT | Inhibikase Therapeutics, Inc. | 431.88M | 1.38% | 486,556 | 1.00 |
| 494 | NRC | NRC Health | 431.72M | -0.05% | 105,756 | 140.00M |
| 495 | OCGN | Ocugen, Inc. | 423.15M | 1.63% | 3,549,348 | 4.47M |
| 496 | EPRX | Eupraxia Pharmaceuticals Inc. | 418.17M | 1.72% | 98,463 | - |
| 497 | EVMN | Evommune, Inc. | 417.45M | 3.02% | 862,587 | 10.00M |
| 498 | BNTC | Benitec Biopharma Inc. | 417.41M | 3.76% | 101,952 | - |
| 499 | KMDA | Kamada Ltd. | 416.05M | 1.26% | 26,436 | 181.68M |
| 500 | STRO | Sutro Biopharma, Inc. | 415.92M | 3.85% | 179,977 | 99.61M |